NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.

Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway. PLoS One (2017) 0.75

Immature Lymphocytes Inhibit Rag1 and Rag2 Transcription and V(D)J Recombination in Response to DNA Double-Strand Breaks. J Immunol (2017) 0.75

The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes. Int J Mol Sci (2017) 0.75

Somatic generation of antibody diversity. Nature (1983) 28.06

Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer (2009) 11.25

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (1999) 10.48

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12

The V(D)J recombination activating gene, RAG-1. Cell (1989) 9.79

RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science (1990) 9.33

Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature (2010) 8.48

Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49

Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49

PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov (2014) 4.81

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood (2003) 4.54

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood (2010) 4.00

Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity (2006) 3.74

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol (1999) 3.42

ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature (2006) 3.35

Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene (2001) 3.32

The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med (1988) 2.93

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood (2009) 2.86

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet (2014) 2.72

Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol (2008) 2.52

SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat Immunol (2008) 2.29

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood (2012) 2.17

Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity. Cancer Res (2008) 2.15

A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat Immunol (2002) 2.07

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev (1998) 1.99

A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity (1996) 1.86

A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity (2005) 1.81

Coupling of V(D)J recombination to the cell cycle suppresses genomic instability and lymphoid tumorigenesis. Immunity (2011) 1.77

Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proc Natl Acad Sci U S A (1994) 1.74

New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nat Rev Immunol (2013) 1.66

Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity (1999) 1.62

Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunol Rev (2012) 1.60

Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J Immunol (2007) 1.59

AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines. Blood (2008) 1.52

Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol Cell (2005) 1.39

Targeting NF-kappaB in hematologic malignancies. Cell Death Differ (2006) 1.38

Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals. Nat Immunol (2009) 1.19

Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes. Immunity (1996) 1.12

Nuclear factor-kappaB, an unappreciated tumor suppressor. Cancer Res (2007) 1.10

Tracing the pre-B to immature B cell transition in human leukemia cells reveals a coordinated sequence of primary and secondary IGK gene rearrangement, IGK deletion, and IGL gene rearrangement. J Immunol (2005) 1.05

NF-kappaB activity marks cells engaged in receptor editing. J Exp Med (2009) 0.98

IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis. Blood (2012) 0.97

GSK690693 delays tumor onset and progression in genetically defined mouse models expressing activated Akt. Clin Cancer Res (2010) 0.96

An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4. Biochemistry (2003) 0.94

Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood (1993) 0.93

NF-kappaB is dispensable for normal lymphocyte development in bone marrow but required for protection of progenitors from TNFalpha. Int Immunol (2006) 0.86

MK5 activates Rag transcription via Foxo1 in developing B cells. J Exp Med (2013) 0.86

Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge. J Immunol (2011) 0.85

A Novel Quantitative Fluorescent Reporter Assay for RAG Targets and RAG Activity. Front Immunol (2013) 0.77

Apurinic/apyrimidinic endonuclease 2 regulates the expansion of germinal centers by protecting against activation-induced cytidine deaminase-independent DNA damage in B cells. J Immunol (2014) 0.77

CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis. J Clin Invest (2014) 0.76

The proximal J kappa germline-transcript promoter facilitates receptor editing through control of ordered recombination. PLoS One (2015) 0.76